Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 450
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +1.3%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07583160	YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer(YS247)	enrolling by invitation	Phase 1	18	Changhai HospitalOTHER	1	May 13, 2026	clinicaltrials
NCT05570994	177Lu-HTK03170 in mCRPC With PSMA Positive Disease	enrolling by invitation	Phase 1 / Phase 2	50	British Columbia Cancer AgencyOTHER	1	Jan 8, 2026	clinicaltrials